Amicus Therapeutics to Announce Third Quarter 2016 Financial Results on November 7, 2016
Nov 01, 2016 11:30 am UTC| Business
CRANBURY, N.J., Nov. 01, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of therapies for rare and orphan diseases, today announced a conference call and live audio webcast on Monday,...
KemPharm, Inc. to Report Third Quarter 2016 Results
Nov 01, 2016 11:30 am UTC| Business
Conference Call and Live Audio Webcast Scheduled for November 9th, 2016, 5:00 p.m. ET CORALVILLE, Iowa, Nov. 01, 2016 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the...
STRATA Skin Sciences Names Frank McCaney as President and CEO
Nov 01, 2016 11:30 am UTC| Business
HORSHAM, Pa., Nov. 01, 2016 -- (NASDAQ:SSKN) STRATA Skin Sciences, Inc. (“STRATA”) a medical technology company dedicated to developing and commercializing innovative products for the treatment and diagnosis of serious...
Provision Interactive Ships Another 200 Units
Nov 01, 2016 11:30 am UTC| Business
CHATSWORTH, Calif., Nov. 01, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO) announced today, that it has shipped an additional 200 3D Savings Center...
FTI Consulting Projects U.S. Online Retail Sales to Approach $440 Billion in 2017
Nov 01, 2016 11:30 am UTC| Business
WASHINGTON, Nov. 01, 2016 -- FTI Consulting, Inc. (NYSE:FCN) today released its U.S. Online Retail Forecast: Omni-Channel Retailing Challenged by Its Success, which projects U.S. online retail sales will approach $440...
Endurance International Group Reports 2016 Third Quarter Results
Nov 01, 2016 11:05 am UTC| Business
Revenue of $291.2 millionNet loss of $(29.8) millionAdjusted EBITDA of $85.2 millionCash flow from operations of $36.2 millionFree cash flow of $26.4 millionTotal subscribers on platform were approximately 5.439 million at...
Nov 01, 2016 11:05 am UTC| Business
NEW YORK, Nov. 01, 2016 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive...